http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2421905-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-545
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34
filingDate 1977-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7023ec054828a22cebea00646e25cae3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76be17c2db2618ebd3f9e70ea2166832
publicationDate 1979-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2421905-A1
titleOfInvention PREPARATION OF A STABLE CEPHALOTHINE-SODIU M POWDER, FOR PARENTERAL ADMINISTRATION
abstract The invention relates to a process for the preparation of substantially crystalline cephalothin-sodium for parenteral administration, in which a cephalothin-sodium solution is cooled from room temperature to -20 degrees C or preferably to -40 degrees C in 1 to 3 hours. in a mixture containing 2 to 10% of a C 1 -C3 alcohol or acetone, the remainder being water, then heated to a temperature of -3 degrees C to -10 degrees C for 3 hours or more, before cooling it again to -20 degrees C or preferably to -40 degrees C. Then a conventional freeze-drying operation is carried out. A stable, crystalline cephalothin-sodium powder which dissolves rapidly in acceptable pharmaceutical diluents in less than 24 hours.
priorityDate 1977-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2306993-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23675321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453470136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701

Total number of triples: 20.